Susquehanna Raises Price Target on Zillow Group, Inc. (ZG) Following 2Q Beat

Zillow (ZG) PT Raised to $42 at RBC Capital Amid Strong Q2

RBC Capital analyst Mark Mahaney reiterated an Outperform rating and raised his price target on Zillow Group (NASDAQ: ZG) (NASDAQ: Z) to $42.00 (from $36.00) following strong Q2 esults, with the company outperforming Street top and bottom line expectations and raising the FY guidance.

What... More

Cowen Boosts PT on Zillow (Z) to $37 Following Q2 Results; Affirms at 'Market Perform'

Cowen and Company boosts its price target on Market Perform-rated Zillow (Nasdaq: ZG)(Nasdaq: Z) from $29 to $37 following Q2 results on Thursday night.

Analyst Thomas Champion commented today: The positives this quarter include 1) significantly better than expected Other Real Estate... More

After-Hours Stock Movers 08/04: (EGLT) (RAX) (PCLN) Higher; (HDP) (SWIR) (FEYE) Lower (more...)

Today's After-Hours Movers

Egalet Corporation (Nasdaq: EGLT) 31.2% HIGHER; announced that the joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 18 to 1 to recommend approval of ARYMO ER (morphine sulfate). ARYMO ER was developed using Egalet's proprietary Guardian Technology for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Hortonworks (NASDAQ:... More

Zillow Group (ZG) Posts Larger Q2 Loss, While Revenues Beat; Raises Revenue Outlook

Zillow Group, Inc. (NASDAQ: ZG) (NASDAQ: Z) reported Q2 EPS of ($0.71), $0.68 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $208.4 million versus the consensus estimate of $205.9 million.

GUIDANCE:

Zillow Group, Inc.... More